Home / Uncategorized / Avastin decision dismays breast cancer patients

Avastin decision dismays breast cancer patients

FDA withdraws blockbuster drug’s approval for breast cancer, saying evidence doesn’t confirm benefit

Read the original post:
Avastin decision dismays breast cancer patients

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top